| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/05/2013 | CN102372789B Peach gum polysaccharide, its extract, preparation method and application thereof |
| 06/05/2013 | CN102357082B Esomeprazole sodium freeze-dried powder injection and preparation method thereof |
| 06/05/2013 | CN102350280B Electrostatic drop generating device with ultrasonic vibration apparatus and method for preparing drug loaded gel microballoon using the same |
| 06/05/2013 | CN102342920B Pharmaceutical composition containing alarelin acetate and preparation method thereof |
| 06/05/2013 | CN102335129B Edaravone medicinal composition for injection and preparation method thereof |
| 06/05/2013 | CN102327209B Preparation method of hydroxyethyl starch 130/0.4 sodium chloride injection |
| 06/05/2013 | CN102309764B Method for aiding polyethylene glycol (PEG) to modify protein medicament by using organic solvent |
| 06/05/2013 | CN102296056B Mycobacteriophage D29 particles and preparation method and use thereof |
| 06/05/2013 | CN102294025B Compound of prostate stem cell antigen polypeptide and nucleic acid and preparation method and application thereof |
| 06/05/2013 | CN102293736B Preparation process of taxol-polymer medicine-carrying micelles |
| 06/05/2013 | CN102274200B Diclofenac sodium sustained release tablets and preparation process thereof |
| 06/05/2013 | CN102232953B Medicinal composition containing Esopiclone and preparation method thereof |
| 06/05/2013 | CN102232932B Pectin-adriamycin coniuncate lyophilized preparation, and preparation method thereof |
| 06/05/2013 | CN102228446B Alprostadil lipid nanosphere freeze-drying injection and preparation method thereof |
| 06/05/2013 | CN102174110B Rabies virus glycoprotein-derived peptide and application thereof |
| 06/05/2013 | CN102151243B Paclitaxel injection and preparation method thereof |
| 06/05/2013 | CN102145171B Method for preparing hydroxyapatite and hydrotalcite composite material with eggshell as raw material |
| 06/05/2013 | CN102145008B Dirithromycin medicinal composition and preparation method thereof |
| 06/05/2013 | CN102114112B Effervescent tablet for improving immunity and preparation method thereof |
| 06/05/2013 | CN102106826B Aripiprazole solid preparation and preparation method thereof |
| 06/05/2013 | CN102106808B Solid preparation and preparation method thereof |
| 06/05/2013 | CN102093831B Hot-melt pressure-sensitive adhesive and preparation method and application thereof |
| 06/05/2013 | CN102083420B Pharmaceutical dosage form comprising polymeric carrier composition |
| 06/05/2013 | CN102049038B Application of gelatinase A inhibitory polypeptide modifier |
| 06/05/2013 | CN102018685B Terazosin pellicle and preparation method thereof |
| 06/05/2013 | CN102000109B Pharmaceutical preparation using hydrogen as therapeutic substance and preparation method thereof |
| 06/05/2013 | CN101962319B Synthetic micromolecule compound capable of conveying bioactive substances and application thereof |
| 06/05/2013 | CN101919869B Forsythoside A drug composite |
| 06/05/2013 | CN101912412B Zeolites for delivery of nitric oxide |
| 06/05/2013 | CN101836951B Ambroxol-hydrochloride-containing oral solution and preparation method thereof |
| 06/05/2013 | CN101810561B Hirudin polyion micelle composition |
| 06/05/2013 | CN101785863B Gel-forming composition |
| 06/05/2013 | CN101721418B External composition containing [gamma]-oryzanol |
| 06/05/2013 | CN101574379B Flavone hippophaes self-emulsifying formulation and preparation method thereof |
| 06/05/2013 | CN101400336B Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 06/05/2013 | CN101336920B Stable medicine combination |
| 06/05/2013 | CN101227892B Buccal delivery system |
| 06/04/2013 | US8455539 CCI-779 concentrate formulations |
| 06/04/2013 | US8455464 Dextrin containing compositions for prevention of adhesions |
| 06/04/2013 | US8455005 Method and compositions for improving animal health |
| 06/04/2013 | US8455002 Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof |
| 06/04/2013 | US8455001 Cellulose derivative and method for production thereof |
| 06/04/2013 | US8454989 Fluid dose on ingestion sheet; accuracte dosage |
| 06/04/2013 | US8454984 Antimicrobial resin compositions |
| 06/04/2013 | US8454976 Recombinant toxin fragments |
| 06/04/2013 | US8454966 Nanoparticles for protein drug delivery |
| 06/04/2013 | US8454964 Three dimensionally crosslinked agarose bead with grass pollen covalently bound; immunotherapy, vaccines, diagnosis |
| 06/04/2013 | US8454951 Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women |
| 06/04/2013 | US8454946 N-maleimidyl polymer derivatives |
| 06/04/2013 | US8454941 O/W-emulsifiers, O/W-emulsions and methods of manufacture thereof |
| 06/04/2013 | CA2664159C Carbonyl-stress improving agent and peritoneal dialysate |
| 06/04/2013 | CA2618799C Aqueous anaesthetic compositions comprising propofol |
| 06/04/2013 | CA2583517C Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkaline agent for enhanced absorption |
| 06/04/2013 | CA2551022C Polyethyleneglycol-modified lipid compounds and uses thereof |
| 06/04/2013 | CA2517369C Polymer-factor viii moiety conjugates |
| 06/01/2013 | CA2797707A1 System and method for alleviating the appearance of scars and/or scar tissue |
| 05/30/2013 | WO2013077847A1 Oral dosage forms for delivering gabapentin |
| 05/30/2013 | WO2013077680A1 Development of novel macromolecule transduction domain with improved cell permeability and method for using same |
| 05/30/2013 | WO2013077620A1 Water insoluble gel composition and method for preparing same |
| 05/30/2013 | WO2013077533A1 Chewable sildenafil citrate tablets in which bitterness is masked, and production method therefor |
| 05/30/2013 | WO2013077414A1 Pharmaceutical composition useful for adhesion prevention or hemostasis |
| 05/30/2013 | WO2013076659A1 Aprepitant l-proline solvates - compositions and cocrystals |
| 05/30/2013 | WO2013076162A1 Formulations useful in the treatment of osteoarticular diseases |
| 05/30/2013 | WO2013076160A1 Sustained release formulations useful in the treatment of diseases |
| 05/30/2013 | WO2013075846A1 Pharmaceutical composition for treatment of allergic reactions |
| 05/30/2013 | WO2013075600A1 Polyethylene glycol-modified integrin blocker hm-3 and use thereof |
| 05/30/2013 | WO2013075394A1 Drug carrier with chelating composite micell and use thereof |
| 05/30/2013 | WO2013075391A1 Electromagnetic therapeutic apparatus and supporting physiotherapy liquid thereof |
| 05/30/2013 | WO2013075253A1 Thiosulfinate antioxidants and methods of use thereof |
| 05/30/2013 | WO2013075244A1 Peptide sequence design and use thereof for peptide-mediated sirna delivery |
| 05/30/2013 | WO2013075186A1 Polymeric nanospheres coated with chitosan folate and use of the same |
| 05/30/2013 | WO2013054110A3 Compositions for binding to amyloid proteins |
| 05/30/2013 | WO2013030702A3 Anthelmintic formulations and treatments |
| 05/30/2013 | WO2012158962A3 Improved peptide pharmaceuticals |
| 05/30/2013 | WO2012140433A8 System for purifying, producing and storing biomolecules |
| 05/30/2013 | US20130138032 ANTICANCER AGENT DELIVERY SYSTEM USING pH-SENSITIVE METAL NANOPARTICLES |
| 05/30/2013 | US20130137851 Targeted delivery of antimicrobial agents |
| 05/30/2013 | US20130137831 Optimized drug conjugates |
| 05/30/2013 | US20130137781 Pharmaceutical preparation for controlling water-soluble drug release |
| 05/30/2013 | US20130137780 Non-adhesive elastic gelatin matrices |
| 05/30/2013 | US20130137779 Process to prepare surface-modified mineral material, resulting products and uses thereof |
| 05/30/2013 | US20130137745 Stabilized statin formulations |
| 05/30/2013 | US20130137741 Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye |
| 05/30/2013 | US20130137715 Pharmaceutical Compositions Containing A Fluoroquinolone Antibiotic Drug |
| 05/30/2013 | US20130137670 Zwitterion solution for low-volume therapeutic delivery |
| 05/30/2013 | US20130137657 Quaternised ammonium cyclodextrin compounds |
| 05/30/2013 | US20130137656 Pharmaceutical/ cosmetic composition comprising hyaluronic acid and treatment of dermatological conditions therewith |
| 05/30/2013 | US20130137638 Conjugated factor viii molecules |
| 05/30/2013 | US20130136789 Agent for treating renal fibrosis |
| 05/30/2013 | US20130136787 Liposomal Camptothecins and Uses Thereof |
| 05/30/2013 | US20130136780 Crosslinked polysaccharide gel compositions for medical and cosmetic applications |
| 05/30/2013 | US20130136775 Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition |
| 05/30/2013 | US20130136756 Antibody drug conjugates (adc) that bind to 24p4c12 proteins |
| 05/30/2013 | US20130136700 Poly-hapten with topical hormone alopecia hair regrowth system |
| 05/30/2013 | US20130136697 Injectable dendrimer hydrogel nanoparticles |
| 05/30/2013 | US20130133551 Composition comprising shellac and/or a salt thereof and sodium starch glycolate |
| 05/30/2013 | CA2856847A1 Oil compositions and methods for increasing hair growth and/or preventing hair loss |
| 05/30/2013 | CA2856672A1 Pharmaceutical composition useful for prevention of adhesion or for hemostasis |
| 05/30/2013 | CA2856642A1 Platelet lysate gel |
| 05/30/2013 | CA2856501A1 A drug carrier with chelating complex micelles and the application thereof |